tizanidine
NDC 60505-0251, tizanidine, tablet, from Apotex Corp..
- Product NDC
- 60505-0251
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076533
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-0251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-0251-1 | 60505025101 | 100 TABLET in 1 BOTTLE (60505-0251-1) |
| 60505-0251-2 | 60505025102 | 1000 TABLET in 1 BOTTLE (60505-0251-2) |
| 60505-0251-3 | 60505025103 | 150 TABLET in 1 BOTTLE (60505-0251-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/01c0d3d3-2373-a1b7-822a-80a66291a248NADAC price for package 60505025102
GET /v1/drugs/nadac/60505025102NADAC price for package 60505025103
GET /v1/drugs/nadac/60505025103
Use it
Look up 60505-0251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-0251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-0251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.